Legal Representation
Attorney
Shauna M. Wertheim
USPTO Deadlines
Next Deadline
2037 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-18)
Due Date
February 18, 2031
Grace Period Ends
August 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 24, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jan 24, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 24, 2025 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN | Loading... |
| Jan 24, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 24, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 24, 2025 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 8, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Oct 8, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 8, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 9, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 8, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 20, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 20, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 10, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 10, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 10, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 10, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 10, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 18, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 18, 2023 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Sep 18, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 18, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 18, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 18, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 31, 2023 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Aug 31, 2023 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Aug 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 30, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 30, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 3, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 16, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Provision of health care advice; providing information relating to opioid dependence
First Use Anywhere:
Sep 3, 2010
First Use in Commerce:
Sep 3, 2010
Additional Information
Design Mark
The mark consists of the stylized word "SUBOXONE". The chemical name of the mark "(BUPRENORPHINE AND NALOXONE)" appears underneath the word "SUBOXONE". To the right of the chemical name is a stylized "C" with three vertical lines inside, followed by the words "SUBLINGUAL FILM".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
SUBOXONE (BUPRENORPHINE AND NALOXONE) CIII SUBLINGUAL FILM
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BUPRENORPHINE AND NALOXONE", "SUBLINGUAL FILM", and the Schedule III Controlled Substance symbol